Oceania Pain

• Vagus Nerve Stimulators Market, by Product Type (Implantable Devices and External Devices), by Application (Epilepsy, Depression & Anxiety, Cluster Headache & Migraine, and Others (Crohn's disease, Dyskinesia, among others)), by End User (Hospitals, Specialty Clinics, and Others (Research Institutions, Ambulatory Surgical Centers, among others)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

  May 30, 2022  |  Published by: Coherent Market Insights  |  USD 4,500

  ... and Others (Research Institutions, Ambulatory Surgical Centers, among others)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Vagus nerve ... Read More

• Asia Pacific Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)

  Apr 10, 2022  |  Published by: The Insight Partners  |  USD 3,450

  ... and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Asia Pacific pharmacogenomics market is expected to reach US$ 2,679.64 million by 2028 from US$ 1,148.36 million in 2021. ... Read More

• Asia-Pacific Intrathecal Pumps Market Databank

  Apr 01, 2022  |  Published by: Magna Intelligence  |  USD 1,500

  ... from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of 11.91%. Read More

< prev 1 2 next >